Serum progesterone and prognosis in operable breast cancer

British Journal of Cancer

Volumn 73, Issue 12, 1996, Pages 1552-1555

  Mohr, P E ^a   Wang, D Y ^b   Gregory, W M ^a   Richards, M A ^c   Fentiman, I S ^a  

^a GUY S HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Breast cancer; Menstrual phase; Progesterone

Indexed keywords

PROGESTERONE;

ARTICLE; BLOOD SAMPLING; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER SURGERY; CANCER SURVIVAL; FEMALE; HORMONE DETERMINATION; HUMAN; MASTECTOMY; MENSTRUAL CYCLE; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL;

EID: 0030037681     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.292     Document Type: Article

References (21)

1. ALEXANDER IE, SHINE J AND SUTHERLAND RL. (1990). Progestin regulation of estrogen receptor messenger RNA in human breast cancer cell lines. Mol. Endocrinol., 4, 821-828.
2. ANDERSON TJ, FERGUSON JP AND RAAB GM. (1982). Turnover in the 'resting' breast: influence of parity, contraceptive pill, age and laterally. Br. J. Cancer, 46, 376-382.
3. BADWE RA, GREGORY WM, CHAUDARY MA, RICHARDS MA, BENTLEY AE, RUBENS RD AND FENTIMAN IS. (1991). Timing of surgery during menstrual cycle and survival of premenopausal women with operable breast cancer. Lancet, 37, 1261-1264.
4. BADWE RA, WANG DY, GREGORY WM, FENTIMAN IS, CHAUDARY MA, SMITH P, RICHARDS MA AND RUBENS RD. (1994). Serum progesterone at the time of surgery and survival in women with premenopausal operable breast cancer. Eur. J. Cancer, 30A, 445-448.
5. BEATSON G. (1896). On the treatment of inoperable cases of carcinoma of the mammae. Suggestions for a new method of treatment. With illustrative cases. Lancet, 2, 104-122.
6. COMPUTING RESOURCE CENTER. (1992). STATA Reference Manual: Release 3, vol. 2, 5th ed., pp. 361-364. Santa Monica, CA.
7. COX DR. (1972). Regression models and life tables. J. R. Stat. Soc., 34, 197-220.
8. FENTIMAN IS AND GREGORY WM. (1993). The hormonal milieu and prognosis in operable breast cancer. Cancer Surveys, 18, 149-163.
9. FENTIMAN IS, GREGORY WM AND RICHARDS MA. (1994). Effect of menstrual phase on surgical treatment of breast cancer. Lancet, 344, 402.
10. KAPLAN EL AND MEIER P (1958). Nonparametric estimation from incomplete observations. Am. Stat. Assoc. J., 53, 457-481.
11. LOW SG, GALEA MH AND BLAMEY R. (1991). Timing breast surgery. Lancet, 338, 691.
12. MANDELOND T, LAVAUD P, SALAZAR G, LAFFARQUE J AND ROCHEFORT H. (1991). Progestins depress estrogen receptor but not cathepsin D level in needle aspirates of benign breast disease. Breast Cancer Res. Treat., 19, 95-102.
13. MASTERS JRW, DRIFE JR AND SCARISBRICK JJ. (1977). Cyclic variation of DNA synthesis in human breast epithelium. J. Natl. Cancer Inst., 58, 1263-1265.
14. PAPA V, HARTMANN KKP, ROSENTHAL SM, MADDUX BA, SHTERI PK AND GOLDFINE ID. (1991). Progestins induce down-regulation of insulin-like growth factor 1 (IGF-1) receptors in human breast cancer cells : potential autocrine role of IGF-1. Mol. Endocrinol., 5, 709-717.
15. PETO R, PIKE MC, ARMITAGE P, BRESLOW NE, COX DR, HOWARD V, MANEL N, MCPHERSON K, PETO J AND SMITH PG (1977). Design and analysis of clinical trials requiring prolonged observation of each patient: II. Analysis and examples. Br. J. Cancer, 35, 1-39.
16. POWLES TJ, ASHLEY SE, NASH AG, TIDY A, GAZET J-C AND FORD HT. (1991). Timing of surgery for breast cancer. Lancet, 337, 1604.
17. SAAD Z, BRAMWELL V, DUFF J, GIROTTI M, JORY T, HEATHCOTE I, TURNBULL I, GARCIA B AND STITT L. (1994). Timing of surgery in relation to menstrual cycle in premenopausal women with operable breast cancer. Br. J. Surg., 81, 217-220.
18. SAINSBURY R, JONES M, PARKER D, HALL R AND CLOSE H. (1991). Timing of surgery for breast cancer. Lancet, 338, 392.
19. SENIE RT, ROSEN PP AND RHODES P. (1991). Timing of breast cancer excision during the menstrual cycle influence duration of disease-free survival. Ann. Intern. Med., 115, 337-342.
20. VERONESI U, LUINI A, MARIANI L, DEL VECCHIO M, ALVEZ D, ANDREOLI C, GIACOBONE A, MERSON M, PACETTI G, RASELLI R AND SACCOZZI R. (1994). Effect of menstrual phase on surgical treatment of breast cancer. Lancet, 343, 1544-1546.
21. WATHEN NC, PERRY L, LILFORD RJ AND CHARD T. (1984). Interpretation of single progesterone measurement in diagnosis of ovulation and defective luteal phase: observation on analysis of the normal range. Br. Med. J., 288, 7-9.